Houston Rx LLC recalls Tirzepatide/Niacinamide 2mL vial
- Recalling company
- Houston Rx LLC
- Product
- Tirzepatide/Niacinamide 2mL vial (40 MG per Vial) Inj 20mg/2mg/mL, RX Only, Houston RX LLC, 15430 Vantage Parkway E STE 220, Houston, TX 77032.
- Reason
- Lack of assurance of sterility.
- Classification
- Class II – may cause temporary or medically reversible health consequences
- Recall date
- Sep 25, 2026
- Reported
- Oct 21, 2026
- Distribution
- Nationwide in the USA.
- Status
- Ongoing
- Quantity
- 64 vials
- Lot / codes
- Lot# TZN-080326-20/2-2, Beyond Use Date: 12/01/2026.
- Company location
- Houston, TX
- Recall type
- Voluntary: Firm initiated
- Recall number
- D-0040-2027
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number D-0040-2027 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.